Product NDC: | 49873-109 |
Proprietary Name: | Stonarhini |
Non Proprietary Name: | Chlorpheniramine maleate, phenylephrine |
Active Ingredient(s): | 2; 5 mg/1; mg/1 & nbsp; Chlorpheniramine maleate, phenylephrine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49873-109 |
Labeler Name: | Sato Pharmaceutical Co., Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20011116 |
Package NDC: | 49873-109-01 |
Package Description: | 4 BLISTER PACK in 1 CARTON (49873-109-01) > 6 TABLET in 1 BLISTER PACK |
NDC Code | 49873-109-01 |
Proprietary Name | Stonarhini |
Package Description | 4 BLISTER PACK in 1 CARTON (49873-109-01) > 6 TABLET in 1 BLISTER PACK |
Product NDC | 49873-109 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlorpheniramine maleate, phenylephrine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20011116 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Sato Pharmaceutical Co., Ltd. |
Substance Name | CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 2; 5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |